Article Details
Retrieved on: 2025-09-16 15:24:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a report released on September 11, Geoff Meacham from Citi maintained a Buy rating on BioNTech SE, with a price target of $140.00.
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here